Global R&D Funding for HIV and STIs
The Need for Centering LMIC Accessibility in Funding Efforts
As STI rates rise and global funding falls, the path forward lies in local leadership, new funding models, inclusive policymaking, and smart integration. In data presented at the STI & HIV World Congress by AVAC and Impact Global Health, a 127% growth in STI R&D funding between 2018 and 2023 from $96m to $218m was promising, but overly dependent on US governments. This growth is likely not sustainable given recent shifts in US policies, and developers, funders, advocates, and other stakeholders must stay accountable to ensure new tools are community-centered and truly address prevention, detection, and treatment needs.
Was this content helpful?
Tell us how we can improve the content.
Was this content helpful?
Thank you for your feedback!